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Auditory Neural Prostheses – A Window to the Future
Hearing loss is one of the commonest congenital anomalies to affect children world-over. 
The incidence of congenital hearing loss is more pronounced in developing countries like 
the Indian sub-continent, especially with the problems of consanguinity. Hearing loss is a 
double tragedy, as it leads to not only deafness but also language deprivation. However, 
hearing loss is the only truly remediable handicap, due to remarkable advances in 
biomedical engineering and surgical techniques. Auditory neural prostheses help to 
augment or restore hearing by integration of an external circuitry with the peripheral 
hearing apparatus and the central circuitry of the brain. A cochlear implant (CI) is a 
surgically implantable device that helps restore hearing in patients with severe-profound 
hearing loss, unresponsive to ampliﬁcation by conventional hearing aids. CIs are 
electronic devices designed to detect mechanical sound energy and convert it into 
electrical signals that can be delivered to the cochlear nerve, bypassing the damaged hair 
cells of the cochlea. The only true prerequisite is an intact auditory nerve. The emphasis is 
on implantation as early as possible to maximize speech understanding and perception. 
Bilateral CI has signiﬁcant beneﬁts which include improved speech perception in noisy 
environments and improved sound localization. Presently, the indications for CI have 
widened and these expanded indications for implantation are related to age, additional 
handicaps, residual hearing, and special etiologies of deafness. Combined electric and 
acoustic stimulation (EAS / hybrid device) is designed for individuals with binaural low-
frequency hearing and severe-to-profound high-frequency hearing loss. Auditory 
brainstem implantation (ABI) is a safe and effective means of hearing rehabilitation in 
patients with retrocochlear disorders, such as neuroﬁbromatosis type 2 (NF2) or 
congenital cochlear nerve aplasia, wherein the cochlear nerve is damaged or absent on 
both sides and hence, a cochlear implant (CI) would be ineffective. In such patients, the 
brainstem implant bypasses the damaged / absent cochlear nerves and directly stimulates 
the cochlear nucleus in the brainstem.  The auditory midbrain implant (AMI) has been 
designed for stimulation of the auditory midbrain, particularly the central nucleus of 
inferior colliculus (ICC). It is used especially in patients with large neuroﬁbromatosis 
type 2 (NF2) wherein tumor induced damage to the brainstem/cochlear nucleus often co-
exists. The efﬁcacy and safety of auditory neural prostheses is well proven. 
Advancements in technology will enhance the beneﬁt provided by these prostheses.  
Correspondence : Prof. Mohan Kameswaran, Senior Consultant ENT Surgeon & Managing 
st
Director, Madras ENT Research Foundation, I   Cross Street, Off II Main Road, Raja 
Annamalaipuram, Chennai-600028.
ACHANTA LAKSHMIPATI ORATION delivered during NAMSCON 2013 at the All-India 
Institute of Medical Sciences, Jodhpur
Prof. Mohan Kameswaran
Senior Consultant ENT Surgeon & Managing Director,
Madras ENT Research Foundation, Chennai
SUMMARY
Ann Natl Acad Med Sci (India), 50(1&2):57-74, 2014
58
Introduction: 
 Hearing loss  is  one of  the 
commonest congenital anomalies to affect 
children world-over. WHO reports that 
nearly 2 - 3 per 1000 live births are found 
to have severe to profound hearing loss, 
making it the most common congenital 
abnormality to affect newborns world 
over.  This scenario is even more 
pronounced in developing countries like 
the Indian sub-continent, especially with 
the problems of consanguinity. Hearing 
loss at birth is considered a social stigma 
even in present day society and ends as a 
double tragedy, as it leads to not only 
deafness but also language deprivation. 
However, hearing loss today, both 
congenital and acquired is the only truly 
remediable handicap, due to remarkable 
advances in biomedical engineering and 
surgical techniques. The advent of 
auditory neural prostheses, which are 
indicated for varying types and extent of 
hearing losses, has successfully broken 
the acoustic barrier, thus integrating 
people with hearing loss into normal 
society and providing them with a highly 
productive quality of life. 
 Auditory neural prostheses help to 
augment or restore hearing by integration 
of an external circuitry with the peripheral 
hearing apparatus and the central circuitry 
of the brain. They are safe and extremely 
effective in restoring hearing to both 
children and adults with severe - profound 
hearing loss, who do not receive beneﬁt 
from conventional hearing aids. These 
implantable devices electronically 
stimulate the cochlea / auditory nerve or 
the higher hearing centers in the brain. The 
audi tory system is  unique in  i t s 
organization because of the phenomenon 
of tonotopicity (place-pitch organization) 
which gives it the opportunity to receive 
and integrate external electronic circuits. 
This is possible because of the low 
potential for rejection of the device by the 
ear and nervous system. Thus, hearing 
restoration is the ﬁrst successful path-
breaking attempt in medical science to 
integrate an electronic device with the 
central nervous system, in order to fully 
restore a lost special sense organ. 
COCHLEAR IMPLANTS
 A cochlear implant (CI) is a 
surgically implantable device that helps 
restore hearing in patients with severe-
profound hearing loss, unresponsive to 
ampliﬁcation by conventional hearing 
aids. CIs are electronic devices designed 
to detect mechanical sound energy and 
convert it into electrical signals that can be 
delivered to the cochlear nerve, bypassing 
the damaged hair cells of the cochlea. 
These electrical signals are processed by 
an external speech processor and sent via a 
radiofrequency interface into an array of 
electrodes implanted surgically within the 
cochlea. The implant system preserves the 
tonotopic map of the cochlea and the 
auditory brain perceives these electrical 
impulses as sound(1).
 Djourno and Eyries published the 
ﬁrst description of cochlear implants in 
1957. In 1961, House used a single 
channel CI and in 1984, Clark developed 
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the popular multichannel implant. FDA 
approval for CI was obtained in 1985. The 
ﬁrst pediatric cochlear implantation was 
done in the US in 1987. Presently, a 
spectrum of implants is available along 
with improved speech processing strat-
egies. Rapid technological advancements 
i n  b i o e n g i n e e r i n g  a n d  i m p l a n t 
manufacturing methods have led to 
miniaturization of the device, with reﬁne-
ment in sound signals, providing better 
“hearing in noise” and music appreciation 
among cochlear implantees. 
Components of a Cochlear Implant 
System 
 T h e  i m p l a n t  h a s  e x t e r n a l 
components, consisting of a microphone 
which receives and transduces sound into 
an electrical waveform, a speech 
processor which divides the signals into 
components for each of the electrodes, 
and a transmitting coil which sends the 
signals across the scalp to the internal 
components. The internal components 
include a receiver-stimulator, which 
receives the signals from the transmitting 
coil and sends it to the electrode array 
which is implanted in the scala tympani of 
the cochlea. (Fig.1)  
 Speech processors are currently 
available as body worn and ear level 
speech processors. All components play 
an important part in converting sound to 
an electrical stimulus. The microphone 
receives and transduces sound into an 
electrical representation. This is done in 
an analog (continuous) fashion. The 
external speech processor and signal-
transfer hardware shapes the electrical 
s ignal .  This requires amplifying, 
compressing, ﬁltering, and shaping. 
Ampliﬁcation is necessary to increase 
some signal levels to the point that they 
can be used in the electrical circuits. 
Compression is a necessary second step of 
signal modulation. The normal human ear 
can hear gradations of sound intensity in a 
range of 120 dB. Persons with severe to 
profound hearing loss do not have this 
same range. In the high frequencies, their 
dynamic range (the difference between 
their absolute threshold and painful 
sound) can sometimes be only 5 dB. The 
range in the lower frequencies is often 
10–25 dB. This means that signiﬁcant 
compression of the sound energy must 
take place in order to render it useful. 
Thus, all cochlear implants employ gain 
control of one kind or another. These 
systems monitor the output voltage and 
adjust the ratio of compression to keep the 
output in a range where it provides useful, 
but not painful stimuli. 
 Filtering of the input signal is the 
Fig. 1 : Cochlear implant-internal 
and external components
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next step. Frequencies between 100 Hz 
and 4000 Hz are generally those most 
important for understanding speech. 
Sound energy is analyzed using several 
different types of ﬁlters. This allows the 
unimportant frequencies to be removed 
and the frequencies of interest to be 
separately modiﬁed. Useful sound 
information is ﬁltered into frequency 
bands. This information can then be 
analyzed for speech patterns and 
channeled to the appropriate portion of the 
electrode array. The transmitter, or outer 
coil, is placed on the mastoid (usually held 
in place by magnets) and sends the 
processed signal to the receiver via 
radiofrequency. The receiver, surgically 
placed in a well over the mastoid, receives 
the signal and sends electrical energy to 
one or many electrodes in the array. The 
electrode array, which lies within the 
cochlea, delivers the electric signal to 
electrodes along its length. The electrical 
ﬁeld generated at these locations serves to 
discharge the neural components of the 
auditory system. The eighth nerve then 
conveys the signal. Just as important as 
any of the man-made components is the 
individual's ability to adjust to, interpret 
and respond to the electrical stimulus. 
Length of time spent without sound 
stimulation of the auditory system, 
presence or  absence of  previous 
exper ience wi th  sound,  personal 
motivation, community or family support, 
and opportunities for rehabilitation have 
been shown to be important factors in 
 
achieving a good outcome(2). These 
f a c t o r s  l i k e l y  a r e  i m p o r t a n t  i n 
understanding signiﬁcant differences in 
pat ient  outcomes despi te  s imilar 
preoperative auditory deﬁcits, surgical 
course, and CI hardware. 
Types of Cochlear Implants 
 Cochlear implants differ in the 
way that they process sound and how they 
present electricity to the hearing nerve. 
Other than the speech processing 
strategies discussed below, there are two 
different ways of encoding sound 
information. The ﬁrst form, analog 
coding, involves continuous coding of the 
sound signal with subsequent transfer to 
the receiver in multiple radiofrequency 
channels. Electrodes are continuously 
stimulated. The second form, digital 
coding, requires sampling of the sound 
waveform and assigning a number to these 
“bits” of information. These bits of 
information are then transferred to the 
receiver where they are decoded. 
Electrodes are stimulated in a pulse 
fashion. Interestingly, neither approach is 
100% effective for all implant users. 
Recently, combining the two schemes has 
seen some success. Cochlear implants can 
also be distinguished by their use of single 
versus multiple channels, the number of 
electrodes, and their use of either 
monopolar or bipolar stimulation. The 
number of electrodes stimulated with 
different electrical stimuli determines the 
“channels” used. In other words, an 
implant may have multiple electrodes but 
if the same information is presented to all 
the electrodes at one time, they are 
essentially functioning as a single channel 
system. In contrast, multichannel devices 
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provide different information to several 
electrodes or groups of electrodes. Early 
implants had only one electrode (and one 
channel); recent advances have led to the 
development of implants with multiple 
electrodes (22) and multiple channels 
(usually 4 to 8). Having more electrodes 
means that multiple channels can be 
localized to areas of the cochlea that are 
most responsive, and stray current that is 
stimulating adjacent structures (facial 
nerve, vestibular nerve) can be rerouted. 
 Cochlear implants can employ 
monopolar or bipolar stimulation. In a 
monopolar system, there is only one 
ground electrode for all the others. The 
ground is usually located at or outside the 
round window. Thus, an electrical ﬁeld is 
created from the stimulated electrode to 
the ground. A bipolar arrangement is such 
that the ground for each electrode is much 
closer (adjacent to, or a few electrodes 
away) .  In  the  h ighly  conduct ive 
environment of the inner ear, monopolar 
stimulation results in some limitations. As 
additional electrodes are stimulated with 
d i f f e r e n t  s t r e a m s  ( c h a n n e l s )  o f 
information, the electrical ﬁelds created 
by stimulated electrodes may interfere 
with ﬁelds at other sites. This makes it 
difﬁcult to stimulate more than one 
electrode at a time, or electrodes that are 
close together. The bipolar conﬁguration 
was an attempt to limit this interaction by 
placing a ground near each electrode, such 
that a smaller ﬁeld would be created with 
less interference and more discrete 
stimulation. Once again, one approach 
does not achieve satisfaction with all 
patients. As a result, many implants offer 
both grounding methods. 
Indications for Cochlear Implantation 
 Bilateral profound cochlear 
h e a r i n g  l o s s ,  u n r e s p o n s i v e  t o 
ampliﬁcation by the most powerful 
hearing aids, is the prime indication for a 
CI. All children below the age of 6 years 
who have congenital or acquired profound 
hearing loss and who will not beneﬁt from 
conventional hearing aids and all adults 
who have lost hearing after acquisition of 
language are ideal candidates. The only 
true prerequisite is an intact auditory 
nerve.  Post l ingual  candidates  do 
extremely well with an implant and in 
prelingual and perilingual candidates, an 
important factor inﬂuencing candidacy is 
neural plasticity, and the emphasis is now 
on implantation as early as possible to 
maximize speech understanding and 
perception. In very young children, 
language acquisition is easier, hence the 
need for early implantation. Owing to the 
loss of neural plasticity in older 
prelingually deaf people, the response to 
implantation may not be optimal and 
extensive preoperative counseling 
regarding realistic expectations is crucial. 
Presently, the indications have expanded 
to include candidates with low frequency 
residual hearing and those with severe 
hearing loss. These expanded indications 
for implantation are related to age, 
additional handicaps, residual hearing, 
and special etiologies of deafness. The 
minimum age for implantation in children 
has come down and children as young as 6 
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months of age have been implanted. 
Because the cochlea is full-size at birth, 
there is no anatomic difﬁculty with 
electrode insertion in very young children. 
Medical and radiological criteria have 
expanded to include signiﬁcant cochlear 
abnormalities including additional 
handicaps, as in syndromic deafness. The 
recent  t rend is  towards bi la teral 
simultaneous or sequential implantation, 
which provides immense beneﬁts of 
binaural hearing. 
Contraindications for Cochlear 
Implantation 
 Not all patients with sensorineural 
hearing loss are good candidates for 
cochlear implantation. For example, 
patients with pure tone thresholds greater 
than 90 dB with residual hearing through 
2000 Hz often do better with hearing aids 
than with implantation. The absence of the 
cochlea (Michel deformity) and a small 
internal auditory canal (associated with 
c o c h l e a r  n e r v e  a p l a s i a )  a r e 
contraindications to implantation on that 
side. Other forms of dysplasia are not 
necessarily contraindications. However, 
when implantation of a dysplastic cochlea 
is to be undertaken, informed consent is 
especially important. Cochlear implants 
in these patients are associated with 
increased risk of poor outcomes, 
cerebrospinal ﬂuid (CSF) leak, and 
m e n i n g i t i s .  A  d i a g n o s i s  o f 
neuroﬁbromatos i s  I I  (h i s to ry  o f 
progressive hearing loss and suggestive 
MRI ﬁndings), mental retardation, 
psychosis, organic brain dysfunction, and 
unrealistic expectations may also be 
contraindications. 
 The presence of active middle ear 
disease is a contraindication to surgery. 
This should be treated and resolved before 
implantation. Patients with a history of 
canal wall down mastoidectomy may need 
surgery to reconstruct the posterior canal 
wall or close off the canal. 
 Meningitis may lead to hearing 
loss and ossiﬁcation of the cochlea. 
Labyrinthitis ossiﬁcans is usually identiﬁ-
able on CT scan and Magnetic resonance 
imaging. Adults and children with acute 
meningitis should be treated with steroids 
to avoid hearing loss. In patients with 
profound hearing loss, implantation must 
be advocated as early as possible. 
 Advanced otosclerosis can also 
cause ossiﬁcation of the basal turn of the 
cochlea. This ﬁnding is most often noted 
on CT scan. This is not a contraindication 
as long as the surgeon is prepared to 
perform a drill out or pursue implantation 
into the scala vestibuli. Patients with 
otosclerosis can achieve excellent results 
from implantation. 
Preoperative Assessment 
 Prior to implantation, a basic 
workup including hematological, chest X-
ray, ECG, TORCH screen need to be 
performed. An audiologic assessment is 
the primary means of determining implant 
c a n d i d a c y .  A u d i o l o g i c a l  a n d 
electrophysiologic investigations include 
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puretone or behavioral audiometry and 
impedance audiometry, otoacoustic 
emissions (OAE), brainstem evoked 
response audiometry (BERA), auditory 
steady state response (ASSR), aided 
audiometry and a hearing aid beneﬁt 
evaluation. Promontory stimulation 
testing can be done in older children and 
adults to assess the response of the cochlea 
to electrical stimulation. 
 High resolution CT scans of the 
temporal bones are done to plan the 
surgical route for implantation, identify 
the vital structures like the facial nerve 
and promontory, and also to rule out any 
ev idence  of  middle  ear  d i sease / 
mastoiditis. MRI is the gold standard 
investigation for the assessment of 
c o c h l e a r  a n a t o m y  a n d  t h e 
vestibulocochlear bundle(3). (Fig.2 &3)
CT/MRI reveal anomalies like Mondini's 
and Michel's aplasia, labyrinthitis 
ossiﬁcans, or absent eighth nerve. Rapid 
advances in genetics and molecular 
b io logy  a re  r evo lu t ion iz ing  ou r 
understanding of congenital deafness, and 
genetic counseling should play an 
important part in prevention. Hence, a 
genetic specialist's opinion is sought in 
patients with syndromic etiology of 
deafness. Children need to get evaluated 
by a child psychologist for assessment of 
mental functions and IQ, prior to implan-
tation and an ophthalmologist needs to 
perform a fundus examination to rule out 
associated visual impairment as seen in 
Usher's syndrome. In children, pre-
implant meningococcal vaccination is 
4
carried out.  Preoperative habilitation is 
important before surgery. Counseling 
patients and parents prior to implantation 
to develop realistic expectations of the 
likely outcome is vital. Hence, candidates 
and parents need to meet and interact with 
other cochlear implantees, to have a 
perspective on the procedure and its 
outcome. 
Cochlear Implantation Surgery 
 The goal of CI surgery is to insert 
the entire electrode array into the scala 
tympani with as little damage as possible 
Fig. 2: MRI of the internal auditory 
meatus showing intact cochlear nerve
Fig. 3: MRI showing bilateral normal 
ﬂuid-ﬁlled cochlea—the “Comma” sign
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to the structure of the inner ear. The 
success of cochlear implantation depends 
on scrupulous attention to technique at all  
the various steps of the procedure. 
Implantation is performed with strict 
aseptic precautions and is done under 
general anesthesia. Surgery is essentially 
the same in children and adults because 
the anatomic structures are of adult 
conﬁguration at birth. However, in very 
young children, there is a slightly 
increased risk of facial palsy and blood 
loss may be an issue. 
 The steps of surgery are as 
f o l l o w s :  u s u a l l y  a n  e x t e n d e d 
postauricular incision is made to expose 
the mastoid cortex. The incision should be 
made more than 1 cm away from the 
location of the coil of the implant. The 
mastoid is drilled out to expose the 
mastoid antrum. Saucerization of the 
cavity is not done. Posterior tympanotomy 
is performed, the promontory and round 
window niche are exposed, without 
exposing the facial nerve. A well for 
receiver-stimulator is fashioned in the 
skull behind the mastoid cavity using a 
template as a guide, and a groove is made 
to connect it to the mastoid cavity. Tie-
down holes are made on either side of the 
w e l l  f o r  s e c u r i n g  t h e  i m p l a n t . 
Cochleostomy is done at the basal turn of 
the cochlea which is opened anterior to the 
round window to make the axis of intro-
duction of the electrode array straight. The 
electrode array is inserted atraumatically 
into the scala tympani using a claw. 
Alternatively, a round window insertion 
may be performed after drilling out the 
anterior lip of the RW niche and 
adequately exposing the secondary 
tympanic membrane (Fig.4). Once the 
electrodes are inserted, diathermy should 
not be used. Fixation of the device and 
electrode array (Fig. 5) and wound closure 
is done. 
 Electrophysiological testing 
(impedance telemetry), neural response 
telemetry and electrically evoked stape-
dial reﬂex thresholds are performed 
intraoperatively to conﬁrm the optimal 
performance of the implant in situ. This 
assures the implant team that the device is 
Fig. 4: Cochlear implantation electrode array in situ
Fig. 5: Cochlear implantation receiver-stimulator 
coil in situ
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functioning and that the patient is 
receiving an auditory stimulus and 
responding appropriately. 
Switch-on and Mapping of Cochlear 
Implant 
 The  swi tch  on  and  speech 
processor tuning is done 3 weeks after 
surgery. Mapping is done at periodic 
intervals till a stable map is achieved. 
Frequent mapping sessions are required, 
and prolonged and intensive (re)habilita-
tion after implantation is essential. 
Habilitation aims at improving receptive 
language skills and expressive skills. The 
habilitation program is started out based 
on baseline skills of the patient; periodical 
assessments of outcome need to be done in 
terms of environmental sound, open set, 
closed set speech, speech discrimination 
and telephonic conversation. The 
recommended period for auditory verbal 
habilitation is 1 year. 
Outcomes of Cochlear Implantation 
 The success of a CI program is 
directly dependent on its ability to address 
the issue of patient expectations and 
balance  i t  wi th  the  outcomes .  A 
multidisciplinary approach is required 
involving the ENT surgeon, audiologist, 
speech therapist ,  auditory verbal 
habilitationist, child psychologist, and 
pediatrician. The patients and their family 
must also be highly motivated for the 
implant. Variables affecting the outcome 
of CI in children are the duration and 
etiology of deafness, age at onset of deaf-
ness, preimplant ampliﬁcation history, 
c o m m u n i c a t i o n  m o d e ,  a g e  a t 
implantation, type of speech processor  
used, and duration of implant usage. In 
very young children, language acquisition 
is easier and hence the need for early 
implantation. Owing to the loss of neural 
plasticity in older prelingual deaf people, 
the response to implantation may not be 
optimal and extensive preoperative 
c o u n s e l i n g  r e g a r d i n g  r e a l i s t i c 
expectations is vital. Factors inﬂuencing 
the overall outcomes are the transparency 
of the program, expertise of the team, 
patient motivation, family support, and 
facilities for habilitation. 
Complications 
 The surgical complication rate 
after cochlear implantation is estimated to 
be less than 5%. The most common prob-
lems are wound infection, bioﬁlms and 
wound breakdown. Rarely, extrusion of 
the device, facial nerve injury, bleeding, 
CSF leaks and meningitis, vertigo, 
tinnitus, facial nerve stimulation, 
numbness of scalp, loss of taste can occur. 
Device-related complications include 
intracochlear damage, slippage of the 
array, breakage of the implant, and 
improper or inadequate insertion and 
device failure. 
 Centers for Disease Control and 
P r e v e n t i o n  ( C D C )  r e c o m m e n d 
vaccination of implanted or soon to be 
implanted patients. Children less than 2 
years of age who have implants should 
receive pneumococcal conjugate vaccine. 
Children with implants 2 years and older 
who have completed the conjugate series 
Prof. Mohan Kameswaran
s h o u l d  r e c e i v e  o n e  d o s e  o f  t h e 
pneumococcal polysaccharide vaccine. 
Children with implants between 24 
months and 59 months who have never 
received vaccination should receive two 
doses of pneumococcal conjugate vaccine 
2 months apart, and then one dose of 
pneumococcal polysaccharide vaccine at 
least 2 months later. Finally, persons aged 
5 years and older with cochlear implants 
should receive one dose of pneumococcal 
polysaccharide vaccine. 
Difﬁcult  Scenarios  in Cochlear 
Implantation 
 With increasing experience in 
cochlear implantation, the indications for 
implant surgery have widened to include 
c o c h l e a r  a n o m a l i e s ,  s y n d r o m i c 
associations, and multiple handicapped 
individuals. Implantation is beneﬁcial in 
such situations. However, the surgeon 
must anticipate challenges during 
implantation and also, the subsequent 
habilitation may be challenging. 
Cochlear Implantation in Labyrinthitis 
Ossiﬁcans 
 A  c o m m o n  a b n o r m a l i t y 
encountered is the ossiﬁed cochlea, 
mostly occurring as postmeningitic 
sequelae, although other pathologies may 
predispose to ossiﬁcation including 
otosclerosis, chronic otitis media, 
ototoxicity, autoimmunity, trauma and 
others. This remains one of the signiﬁcant 
surgical challenges for the otologist. It is 
diagnosed with a CT/MRI scan. On 
conﬁrmation of an obstructed basal turn, 
the proximal turn is drilled with a 
microdrill to a depth of 6–8 mm until an 
open lumen is discovered, and the 
electrode array is inserted. In total 
ossiﬁcation, a complete drill-out of the 
basal turn is required and the implanted 
array is seated in a trough that surrounds 
the modiolus. A double-array implant may 
be used with some electrodes into the 
basal turn and others into the second turn. 
Cochlear Implantation in Mondini's 
Deformity/Large Vestibular Aqueduct 
Syndrome 
 Cerebrospinal ﬂuid leak during 
cochleostomy has to be sealed. A variety 
of techniques may be used to help control 
the ﬂow of CSF including ﬁrm plugging of 
the cochleostomy using soft tissue 
coupled with reducing the ﬂow of CSF by 
lumbar drainage and intravenous 
mannitol drip, if necessary. Such leaks 
may also be encountered in cases of 
enlarged vestibular aqueduct (LVAS). The 
'pulsatile stapes sign' has been described 
by the author to diagnose LVAS intra-
operatively. 
Auditory Neuropathy/Auditory Dys-
synchrony Spectrum Disorder 
 Normal outer hair cell (OHC) 
function and dys-synchronous neural 
responses characterize this disorder. 
Patients will show a normal OAE with 
absent BERA waveforms, which is 
pathognomonic of this condition. 
C o c h l e a r  i m p l a n t s  a r e  a  v i a b l e 
management option for patients with 
auditory neuropathy/auditory dys-
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s y n c h r o n y  s p e c t r u m  d i s o r d e r 
(AN/ADSD) and are beneﬁcial in 
bypassing the desynchronous neural 
network, but the outcomes may be 
suboptimal or guarded, and the family 
needs to be counseled regarding the same. 
Cochlear Implantation in Multihandi-
capped Individuals 
 Early diagnosis and rehabilitation 
of deafness and additional handicaps are 
crucia l .  An implant  helps  in  the 
habilitation of deafness and other 
handicaps as well. However, patient 
selection criteria must be stringent. 
Evaluation, surgical intervention, and 
postimplantation management of these 
patients can be challenging. 
M i n i m a l l y  I n v a s i v e  C o c h l e a r 
Implantation 
 Due to improvements in CI 
technology, smaller and more powerful 
implantable cochlear implants have 
evolved which has enabled smaller 
external incisions, smaller skin ﬂaps, 
shortened surgical time, and faster 
h e a l i n g .  C u r r e n t  t e c h n i q u e s  i n 
cochleostomy (Peep-hole cochleostomy) 
and round window electrode insertion 
(sof t  inser t ion)  have resul ted  in 
preservation of residual hearing. 
Bilateral Cochlear Implantation 
 Bilateral CI has signiﬁcant 
beneﬁts which include improved speech 
perception in noisy environments and 
improved sound localization.(5) The 
advantages include elimination of head-
shadow effect, signiﬁcant beneﬁts from 
summation effects (improvement in 
hearing threshold from redundant 
information presented to each ear) and 
squelch effects (improvement in hearing 
threshold from brainstem processing of 
inter-aural time and intensity differences). 
 
Cochlear Endoscopy 
 Cochlear endoscopy was ﬁrst 
described by Balkany and colleagues in 
1990 who used ﬂexible ﬁberoptic 
m i c r o e n d o s c o p e s  ( 0 . 7 – 1  m m 
diameter)(6). Currently, the indications 
for cochlear endoscopy are limited and it 
is not recommended routinely during CI. 
The present indications are visualization 
of obstructed segments of the cochlea in 
labyrinthitis ossiﬁcans and the interior of 
the cochlea in cochlear dysplasia. 
Visualization of the interior of the cochlea 
will help in preinsertion assessment as 
well as to verify proper insertion of the 
implant. 
Perimodiolar and Midscalar Cochlear 
Implantation 
 These implants are assumed to 
have a  s l ight ly  enhanced speech 
perception. After the electrodes are 
inserted into the cochlea, the stylet is 
withdrawn and the electrodes come into a 
perimodiolar/midscalar position. The 
electrode-neural interface seems to be 
minimal in this position, and hence clarity 
of auditory inputs are much better. 
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Future Directions In Cochlear 
Implantation 
 CI  surgery and technology 
continue to evolve. In the future, fully 
implanted devices (l ike the TIKI 
prototype), improved speech coding 
strategies, cochlear hair cell, and nerve 
growth factors used in conjunction with an 
implant may be available. 
MERF Experience
 N i n e  h u n d r e d  c o c h l e a r 
implantations were performed over 15 
years. Majority of candidates were pre-
lingual, 10% candidates were postlingual 
and 20% were peri-lingual. Outcomes 
were dependent on age at implantation 
and duration of deafness, the best 
o u t c o m e s  w e r e  o b s e r v e d  w h e n 
implantation was performed before 3 
years of age. Children responded better 
with very good outcomes if implanted 
early.  Children in 1-5 yrs age group 
achieved category 7 (use telephone) on 
CAP score and category 5 (connected 
speech intelligible to all listeners) on SIR 
score earlier than children in 6 -10 years 
age group. 
Electroacoustic Stimulation
 One of the latest applications of 
implantable hearing technology combines 
electric and acoustic stimulation (EAS) 
into a hybrid device designed for 
individuals with binaural low-frequency 
hearing and severe-to-profound high-
frequency hearing loss. 
Indications 
 Electro-acoustic stimulation is the 
latest strategy conceptualized for residual 
hearing preservation in the implanted ear, 
in order to provide combined electrical 
stimulation and acoustic hearing for 
candidates with bilateral high-frequency, 
severe-to-profound sensorineural hearing 
loss. The addition of the electrical 
stimulation to such patients, with existing 
residual low frequency hearing, can 
provide clear speech recognition in 
background noise and better appreciation 
of musical  notes.  Low-frequency 
thresholds generally can range from 20 dB 
HL to 60 dB HL through 750 Hz, and 
thresholds at 1000 Hz and above must 
g e n e r a l l y  e x c e e d  6 0 – 7 0  d B  H L 
Preoperative speech perception criteria 
require that aided consonant nucleus 
consonant (CNC) monosyllabic word 
recognition score in the ear to be 
implanted cannot exceed 50–60%. 
Individuals with binaural high frequency 
hearing loss may not gain signiﬁcant 
beneﬁ t  f rom t rad i t iona l  hea r ing 
ampliﬁcation. Their relatively good low-
frequency hearing may disqualify them 
from conventional cochlear implant (CI) 
candidacy. As a result, individuals with 
good low-frequency hearing and severe-
to-profound high-frequency hearing loss 
can experience signiﬁcant difﬁculty in 
everyday communication, particularly in 
noisy backgrounds, where low-frequency 
information alone is not sufﬁcient to allow 
high levels of speech understanding. 
 In recent times, implant surgeons 
are employing soft surgical techniques 
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which include a smaller cochleostomy or 
round window insertion, performed 
gently with thinner electrode arrays and/or 
perimodiolar electrodes (atraumatic 
cochlear insertion) which contribute to 
hearing preservation with standard 
cochlear implants. The hybrid device uses 
a shortened CI electrode array that is 
inserted just 10-20 mm into the cochlea 
(versus 20-30 mm for a conventional 
implant), covering the basal two third of 
the cochlea. A successful surgical 
outcome allows for monaural electric 
stimulation of the basal cochlea for high-
frequency information without damaging 
apical cochlear structures that transmit 
low-frequency acoustic information. This 
combination allows for the integration of 
electric and acoustic perception in the 
same ear. 
Components of Hybrid Implant 
 The EAS system consists of two 
parts: a CI with a soft and ﬂexible 
electrode array for preservation of 
residual low frequency hearing, and a 
speech processor which combines the CI 
component with conventional acoustic 
stimulation in one comfortable and 
compact device. EAS patients wear an in-
the-ear (ITE) hearing aid in the implanted 
ear (which can amplify sound signals up to 
43 dB acoustical gain) in combination 
with an external ear-level or body-worn 
speech processor or an integrated hearing 
aid/speech processor on the implanted 
side. Surgery for EAS is very similar to 
conventional cochlear implantation, and 
round window insertion is often preferred 
for optimal hearing preservation. The 
hybrid implant  has a special ized 
microphone competent for parallel 
processing of sounds. The acoustic and 
electric digital sound processing compo-
nents of the EAS processor receive sound 
signals from this single microphone. The 
parallel processing of these signals is 
performed separately and optimized for 
both acoustic stimulation (focusing on 
l o w - f r e q u e n c y  h e a r i n g )  a n d  C I 
stimulation (focusing on high-frequency 
hearing). This microphone automatically 
adjusts to incoming sounds in order to 
capture all the vital cues necessary for 
understanding speech clearly without 
requiring special programming or the use 
of a switch to shufﬂe between the two 
modes of hearing. 
 Enhanced music perception is one 
of the major beneﬁts reported by 
candidates who receive EAS implants. 
Auditory Brainstem Implants
 Auditory brainstem implantation 
(ABI) is a safe and effective means of 
hearing rehabilitation in patients with 
re t rocochlear  d i sorders ,  such  as 
neuroﬁbromatosis type 2 (NF2) or 
c o n g e n i t a l  c o c h l e a r  n e r v e 
hypoplasia/aplasia, wherein the cochlear 
nerve is damaged or absent on both sides 
and hence, a cochlear implant (CI) would 
be ineffective. In such patients, the 
brainstem implant bypasses the damaged / 
absent cochlear nerves and directly 
stimulates the cochlear nucleus in the 
brainstem(7).  
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Indications For Auditory Brainstem 
Implantation 
 Multichannel ABI are USFDA 
approved for adult patients with NF2 
tumors involving both vestibule-cochlear 
nerves. The implant is usually placed in 
the lateral recess of the fourth ventricle 
after tumor resection(8). (Fig.6) 
 The indications for ABI have 
expanded onto non-tumoral (NT) cases, 
such as congenital bilateral cochlear nerve 
aplasia(9). In such cases, the pediatric ABI 
helps bypass the non-functioning 
hypoplastic or absent cochlear nerves and 
stimulates the cochlear nucleus directly, 
thereby restoring auditory sensation in 
children. Other indications for ABI 
include bilateral totally ossiﬁed cochleae 
in which a CI cannot be used, bilateral 
auditory neuropathy, bilateral temporal 
bone fractures and demyelinating diseases 
affecting the eight cranial nerves, but 
sparing at least one cochlear nucleus. 
Contraindications to ABI include 
previous stereotactic radiotherapy which 
has the risk of radiation necrosis of the 
cochlear nucleus region, and anatomic 
distortion and ﬁbrosis. ABI may not be 
possible in very large tumors which cause 
distortion of the brainstem. 
 A multidisciplinary collaboration 
between neurotologist, neurosurgeon, 
implant audiologist and neuro-anesthetist 
is required in order to perform this 
intricate and sophisticated surgery. Most 
patients with the implant have good 
auditory awareness with appreciation of 
environmental sounds, but obtain more 
modest beneﬁt with regard to speech 
perception. Majority of ABI patients use 
the implant, in order to facilitate lip 
reading while some can, in varying 
degrees, comprehend speech directly. It 
has been demonstrated that the ABI with 
surface electrodes may provide sufﬁcient 
stimulation of the central auditory system 
in adults for open-set speech recognition. 
These favorable results motivated the 
clinicians to extend ABI indications onto 
Fig. 6: Two ends of the auditory brainstem implant
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children with profound hearing loss who 
are not candidates for CI. 
The incidence of cochlear nerve aplasia in 
the overall population world over is very 
low, estimated at one in every 100,000 
newly born babies wherein ABI is 
i n d i c a t e d .  A u d i t o r y  b r a i n s t e m 
implantation appears to be more effective 
in non-tumor diseases of the auditory 
nerve or cochlea than in patients with NF2 
tumors. 
Clinical Assessment for Auditory 
Brainstem Implantation 
 A meticulous work up – audiology 
& electrophysiology and high resolution 
r a d i o - i m a g i n g  w i t h  c o m p u t e d 
tomography (CT)/magnetic resonance 
imaging (MRI) of the brain and inner ear 
is mandatory.
 In children, a detailed genetic 
study, neurological and psychomotor 
assessment is necessary apart from the 
routine work up as done for cochlear 
implantation. 
Operative Procedure for Auditory 
Brainstem Implantation 
 For successful ABI surgery, a few 
important issues such as patient selection, 
choice of device, choice of approach, 
technique of tumor removal, knowledge 
o f  m i c r o a n a t o m i c a l  v a r i a t i o n s , 
intraoperative identiﬁcation of the 
cochlear nucleus and prevention of 
complications have to be considered. The 
procedure is done under intensive 
neuroanesthesia with intraoperative 
c r a n i a l  n e r v e  m o n i t o r i n g . 
Translabyrinthine approach or lateral 
s u b o c c i p i t a l  a p p r o a c h  i s  u s e d . 
Craniotomy exposes the transverse sinus 
superiorly and sigmoid sinus laterally. 
Dura needs to be opened by a vertical 
incision 1 cm away from the sigmoid 
s inus ,  and  i s  reﬂec ted  la te ra l ly. 
Cerebrospinal ﬂuid (CSF) is let out from 
the basal cisterns to make the cerebellum 
lax. Cerebellum is retracted medially to 
reach the cerebellopontine (CP) angle 
where the VII and VIII nerve complex is 
identiﬁed. Inferiorly, the lower cranial 
nerves are seen and followed medially 
onto the foramen of Luschka where the 
choroids plexus is identiﬁed. Further 
dissection is done to reach the ﬂoor of the 
IV ventricle, where a constant vein called 
the straight vein is present, which leads to 
the site of the cochlear nucleus. In tumoral 
cases as in NF2, tumor excision via the 
same approach precedes the implantation. 
After tumor excision, the landmarks (VII, 
VIII and IX cranial nerves, choroid 
plexus) for the foramen of Luschka are 
identiﬁed. Location of the lateral recess 
can be conﬁrmed by noting the egress of 
CSF during valsalva maneuver. The ABI 
electrode array is then inserted into the 
lateral recess and positioned once the 
cochlear nucleus is well delineated. 
Initially, temporary electrodes are placed 
on it and electrically evoked auditory 
brainstem responses (EABR), early mid-
latency responses (EMLR), and device 
telemetry (DT) are performed to check the 
optimal positioning and functioning of the 
electrodes. Once integrity is conﬁrmed, 
the permanent electrodes are then placed 
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onto the cochlear nucleus and positioned 
with ﬁbrin glue and surgicel. (Fig. 7 & 8)
 The receiver-stimulator coil is 
placed in a bed created in the area 
posterosuperior to the craniotomy. It is 
placed at least 10 mm behind the edge of 
the auricle and above the canthomeatal 
l i n e ,  a n d  i s  a n g l e d  3 0 – 4 5 ° 
posterosuperiorly. Tie-down holes are 
made on either side of the receiver-
stimulator for securing the implant. 
Reconﬁrmation of implant function is 
done with electrophysiological tests. The 
stimulus to ABI is delivered by an external 
component comprising of a microphone, a 
signal processor and a transmitter coil 
very similar to the CI. Dura is closed 
primarily in a water-tight fashion. 
Postoperative neurointensive care is 
necessary with cranial nerve monitoring. 
Habilitation After Auditory Brainstem 
Implantation 
 The device is switched on 2 
months after implantation, providing 
sufﬁcient time for wound healing and full 
recovery. Switch on needs to be done in 
the operat ion theater  with neuro 
monitoring and adequate preparation for 
active CPR, as there may be inadvertent 
stimulation of other brainstem nuclei and 
the possibility of non-auditory stimulation 
of vital centers. The stimulus threshold 
and comfort level on each electrode is 
ascertained. Postoperative CT scan and X-
ray of skull conﬁrm the position of the 
ABI in situ. (Fig. 9) Habilitation of ABI 
patients requires intense dedication and 
ski l l  on the part  of  the auditory 
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habilitationist and audiologist, along with 
adequate motivation and family support 
from the patient's side. 
Outcomes of Auditory Brainstem 
Implantation 
 I n t e n s i v e  a u d i t o r y  v e r b a l 
habilitation is then initiated and continues 
for a minimum period of 1 year (as advo-
cated for CI) with periodical EABR and 
EMLR - tests done during the follow-up 
for conﬁrmation of device integrity and 
assessment of optimal performance of the 
implantee. Most implantees develop very 
good sound awareness and good gross 
auditory discrimination with appropriate 
habilitation. Achievement of lucid 
environmental sound perception with 
pitch discrimination for closed set speech 
is often the culmination of the habilitation 
process. 
MERF Experience
 Of the seven candidates who 
underwent ABI, one patient was post-
lingual and had neuroﬁbromatosis type II 
and six were pre-lingual with bilateral 
cochlear and cochlear nerve aplasia. The 
outcome assessment is by habilitation 
scores (CAP, SIR, MUSS, MAIS), 
electrically evoked auditory brainstem 
response and cortical auditory evoked 
potentials. 
Auditory Midbrain Implant
 The auditory midbrain implant 
(AMI) has been designed for stimulation 
of the auditory midbrain, particularly the 
central nucleus of inferior colliculus 
(ICC). 
 Cochlear implantation (CI) is 
ineffec t ive  for  those  wi thout  an 
implantable cochlea or an absent, thin 
non-functional or tumor of the vestibulo-
cochlear nerve. These patients can be 
implanted with the auditory brainstem 
implant (ABI), which directly stimulates 
the surface of the cochlear nucleus. 
Unfortunately, ABI has achieved limited 
success in providing environmental 
awareness and auditory sensations, 
especial ly  in  pat ients  with large 
neuroﬁbromatosis type 2 (NF2) wherein 
tumor induced damage to the brain-
stem/cochlear nucleus often co-exists.  
The midbrain is a target, is more surgically 
accessible than the cochlear nucleus in the 
lateral recess and hence AMI has today 
emerged as a valuable alternative to the 
ABI. The central nucleus of ICC is 
tonotopically well organized like the 
cochlea and accesses all ascending 
auditory impulses from the peripheral 
pathways(10). AMI offers advantage over 
the ABI in that it can be surgically 
implanted under direct visual exposure of 
the target ICC region, with less risk of 
damaging critical brainstem structures 
and cranial nerves. Stimulation of the ICC 
site helps in enhancing the lip-reading 
c a p a b i l i t i e s  a n d  a l s o  p r o v i d e s 
e n v i r o n m e n t a l  a w a r e n e s s  w i t h 
improvement in speech perception 
performance.
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Conclusion 
 A d v a n c e s  i n  b i o m e d i c a l 
engineering have led to the development 
of auditory neural prostheses such as 
cochlear implants and auditory brainstem 
implants which have helped habilitate 
patients with severe – profound hearing 
loss. Their efﬁcacy and safety are well 
proven. Advancements in technology will 
enhance the beneﬁt provided by these 
prostheses.  
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